Sector: Materials
ECOLAB INC · Meeting: May 7, 2026
Directors FOR
10
Directors AGAINST
3
Say on Pay
FOR
Auditor
FOR
Election of 13 Director Nominees Named in the Proxy Statement to a One-Year Term Ending in May 2027
Against Analysis
Mr. Doukeris is CEO of AB InBev and sits on the boards of Ambev S.A. and Budweiser Brewing Company APAC Limited — both publicly traded — giving him two outside public board seats, which exceeds the policy limit of one for a sitting CEO; the board's explanation that these seats are integral to his AB InBev role does not override this bright-line governance concern.
Mr. Green is currently Chairman, President, and CEO of West Pharmaceutical Services and simultaneously serves on its public company board, plus the Ecolab board — that equals two outside public board seats for a sitting CEO, which exceeds the policy limit.
Mr. Zillmer is currently CEO of Aramark and sits on Aramark's board plus CSX Corporation's board, giving him two outside public board seats as a sitting CEO — one more than the policy permits; his high meeting attendance and deep industry knowledge are noted, but the overboarding concern is a bright-line policy trigger.
For Analysis
Joined in 2024 (within 24 months), so exempt from TSR trigger; brings relevant technology and AI expertise with no overboarding, independence, or attendance concerns.
Independent director with relevant experience; ECL's 3-year TSR of +68.1% outperforms peer median by +30.8pp, well below the 65pp threshold needed to trigger a vote against, and no other policy flags apply.
As sitting CEO serving on one outside public company board (Delta Air Lines), he is within the policy limit of fewer than two outside public board seats; ECL's 3-year TSR substantially outperforms peers and no TSR trigger fires.
Joined in 2025 (within 24 months), so exempt from TSR trigger; brings relevant supply chain and food-service expertise with no other policy flags.
Holds three public company board seats as a non-executive director, within the policy limit of four; ECL's strong 3-year TSR does not trigger the underperformance threshold and no other policy flags apply.
Serves on one outside public company board (Caterpillar); ECL's 3-year TSR of +68.1% outperforms the peer median by +30.8pp, far short of the 65pp trigger, and no other flags apply.
Holds one outside public company board seat; ECL's 3-year TSR comfortably clears the peer comparison threshold and no other policy flags are present.
Holds two outside public company board seats as a non-executive director, well within the policy limit; ECL's strong TSR record does not trigger the underperformance test and no other flags apply.
Holds three outside public company board seats as a non-executive director, within the policy limit of four; ECL's TSR record relative to peers does not trigger the underperformance threshold and no other flags apply.
Joined in August 2025 (within 24 months), so exempt from TSR trigger; brings strong financial and audit expertise with no other policy flags.
The ECL board does not trigger any TSR underperformance concerns — ECL's 3-year total return of +68.1% outperforms the disclosed peer median by +30.8 percentage points, well below the 65pp threshold required to trigger votes against directors. Three directors are flagged for overboarding: Michel Doukeris and John Zillmer are sitting CEOs with two outside public board seats each, and Eric Green is the sitting CEO of West Pharmaceutical Services who also serves on that company's board plus Ecolab's board. All other directors pass the policy screens.
CEO
Christophe Beck
Total Comp
$17,404,935
Prior Support
N/A
CEO total compensation of $17.4 million is within a reasonable range for the CEO of a $74.6 billion market cap specialty chemicals and services company, and Ecolab delivered strong 2025 results including 13% adjusted earnings-per-share growth and a 34th consecutive annual dividend increase. The pay structure is appropriately variable, with long-term equity awards (60% performance-based stock awards and 40% stock options) making up the majority of total pay, tied to multi-year organic return on invested capital and relative total shareholder return metrics. ECL's 3-year stock return of +68.1% meaningfully outperforms both the peer group median (+37.3%) and the XLB sector ETF (+31.7%), supporting a conclusion that above-target incentive payouts are well aligned with the shareholder experience.
Auditor
PricewaterhouseCoopers LLP
Tenure
N/A
Audit Fees
N/A
Non-Audit Fees
N/A
PricewaterhouseCoopers LLP is a Big 4 firm appropriate for a company of Ecolab's size and complexity; auditor tenure is not disclosed in the filing text provided so the tenure trigger cannot fire, and no fee data was included in the extracted filing text to calculate a non-audit fee ratio — absent confirmed data triggering a No, the default vote is FOR.
1 proposal submitted by shareholders
Proposal 4
John Chevedden is a well-known individual governance activist whose proposals deserve serious consideration on the merits. However, Ecolab has a genuinely robust Lead Independent Director structure — the Lead Director is elected annually by independent directors, chairs executive sessions at every board meeting, controls agendas and information flow, and engages directly with shareholders — which substantially addresses the core oversight concern behind this proposal. Critically, the company reports that shareholders representing over 50% of outstanding shares were directly engaged in 2024 and 'generally supported the current Board leadership structure,' indicating real shareholder preference rather than management spin. Given that similar proposals have been rejected multiple times, no disclosed prior-year support approaching the 40-50% range that would create a strong signal for change, and a genuinely functioning independent oversight mechanism already in place, a vote against is appropriate at this time.
Ecolab's 2026 annual meeting presents a generally clean ballot: say-on-pay earns support given strong performance and well-structured variable pay, and the auditor ratification passes without disclosed fee or tenure concerns. Three director nominees — Michel Doukeris, Eric Green, and John Zillmer — are flagged for overboarding as sitting CEOs holding multiple outside public board seats, and the independent board chair stockholder proposal from John Chevedden is voted against given the company's robust Lead Independent Director structure and documented shareholder support for the current arrangement.
21 companies disclosed in 2026 proxy filing
